These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 19605741)

  • 1. How to dose infliximab in rheumatoid arthritis: new data on a serious issue.
    van Vollenhoven RF
    Ann Rheum Dis; 2009 Aug; 68(8):1237-9. PubMed ID: 19605741
    [No Abstract]   [Full Text] [Related]  

  • 2. Increasing the infliximab dose in rheumatoid arthritis patients: a randomised, double blind study failed to confirm its efficacy.
    Pavelka K; Jarosová K; Suchý D; Senolt L; Chroust K; Dusek L; Vencovský J
    Ann Rheum Dis; 2009 Aug; 68(8):1285-9. PubMed ID: 19351624
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of rituximab for the treatment of rheumatoid arthritis: the Latin American context.
    Soriano ER; Galarza-Maldonado C; Cardiel MH; Pons-Estel BA; Massardo L; Caballero-Uribe CV; Achurra-Castillo AF; Barile-Fabris LA; Chávez-Corrales J; Díaz-Coto JF; Esteva-Spinetti MH; Guibert-Toledano M; Palazuelos FI; Keiserman MW; Lomonte AV; Mota LM; Pineda Villaseñor C; Alarcón GS;
    Rheumatology (Oxford); 2008 Jul; 47(7):1097-9. PubMed ID: 18463144
    [No Abstract]   [Full Text] [Related]  

  • 4. Increase in methotrexate dose in patients with rheumatoid arthritis who have an inadequate response to infliximab.
    Ornetti P; Solau E; Gaudin P; Sibilia J; Berthelot JM; Puechal X; Tavernier C; Maillefert JF;
    Ann Rheum Dis; 2005 Sep; 64(9):1379-80. PubMed ID: 16100349
    [No Abstract]   [Full Text] [Related]  

  • 5. Timing of DAS28 in infliximab therapy.
    Armstrong DJ; Bruce IN
    Rheumatology (Oxford); 2005 Sep; 44(9):1203-4; author reply 1204. PubMed ID: 15870143
    [No Abstract]   [Full Text] [Related]  

  • 6. [Experiences with infliximab in the treatment of active rheumatoid arthritis and spondyloarthropathy].
    Dahlin J; Sørensen SF
    Ugeskr Laeger; 2003 Nov; 165(48):4646-9. PubMed ID: 14677464
    [No Abstract]   [Full Text] [Related]  

  • 7. Observational cohort studies and well controlled clinical trials--we need them both!
    Furst DE
    J Rheumatol; 2004 Aug; 31(8):1476-7. PubMed ID: 15290723
    [No Abstract]   [Full Text] [Related]  

  • 8. Rituximab fixed retreatment versus on-demand retreatment in refractory rheumatoid arthritis: comparison of two B cell depleting treatment strategies.
    Teng YK; Tekstra J; Breedveld FC; Lafeber F; Bijlsma JW; van Laar JM
    Ann Rheum Dis; 2009 Jun; 68(6):1075-7. PubMed ID: 19435725
    [No Abstract]   [Full Text] [Related]  

  • 9. Infusion reaction to infliximab in a patient with rheumatoid arthritis after discontinuation over 1 year and readministration.
    Toki H; Momohara S; Tsukahara S; Ikari K
    J Rheumatol; 2008 Sep; 35(9):1896-7; author reply 1897. PubMed ID: 18785300
    [No Abstract]   [Full Text] [Related]  

  • 10. Shortening infusion times for infliximab administration.
    Buch MH; Bryer D; Lindsay S; Rees-Evans B; Fairclough A; Emery P
    Rheumatology (Oxford); 2006 Apr; 45(4):485-6. PubMed ID: 16352636
    [No Abstract]   [Full Text] [Related]  

  • 11. Rituximab (Rituxan) for rheumatoid arthritis.
    Med Lett Drugs Ther; 2006 Apr; 48(1233):34-5. PubMed ID: 16625143
    [No Abstract]   [Full Text] [Related]  

  • 12. Long-term treatment of rheumatoid arthritis with tumour necrosis factor alpha blockade: outcome of ceasing and restarting biologicals.
    Buch MH; Marzo-Ortega H; Bingham SJ; Emery P
    Rheumatology (Oxford); 2004 Feb; 43(2):243-4. PubMed ID: 14739466
    [No Abstract]   [Full Text] [Related]  

  • 13. Efficacy and safety of infliximab for the treatment of psoriatic arthritis.
    Ritchlin C
    Nat Clin Pract Rheumatol; 2006 Jun; 2(6):300-1. PubMed ID: 16932707
    [No Abstract]   [Full Text] [Related]  

  • 14. Reactions to infliximab in patients with rheumatoid arthritis.
    Sakellariou GT; Chatzigiannis I
    J Rheumatol; 2005 Jul; 32(7):1411-2. PubMed ID: 15996088
    [No Abstract]   [Full Text] [Related]  

  • 15. Dose escalation of infliximab therapy in arthritis patients is related to diagnosis and concomitant methotrexate treatment: observational results from the South Swedish Arthritis Treatment Group register.
    Kristensen LE; Geborek P; Saxne T
    Rheumatology (Oxford); 2009 Mar; 48(3):243-5. PubMed ID: 19106164
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rapid and complete resolution of proteinuria due to renal amyloidosis in a patient with rheumatoid arthritis treated with infliximab.
    Elkayam O; Hawkins PN; Lachmann H; Yaron M; Caspi D
    Arthritis Rheum; 2002 Oct; 46(10):2571-3. PubMed ID: 12384913
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is IV infliximab better than IV methylprednisolone for the treatment of patients with RA when methotrexate fails?
    Smith MD
    Ann Rheum Dis; 2005 Mar; 64(3):512; author reply 512. PubMed ID: 15708914
    [No Abstract]   [Full Text] [Related]  

  • 18. A single course of rituximab does not abrogate anti-infliximab antibodies in patients with rheumatoid arthritis.
    van den Bemt BJ; Vos K; den Broeder AA; Blom M; Thurlings RM; Bartelds GM; Stapel SO; Barrera P; Tak PP; Nurmohamed MT; Wolbink GJ
    Ann Rheum Dis; 2009 Aug; 68(8):1368-9. PubMed ID: 19605744
    [No Abstract]   [Full Text] [Related]  

  • 19. Improvement with rituximab in a patient with both rheumatoid arthritis and myasthenia gravis.
    Kerkeni S; Marotte H; Miossec P
    Muscle Nerve; 2008 Oct; 38(4):1343-5. PubMed ID: 18816604
    [No Abstract]   [Full Text] [Related]  

  • 20. Comparative multidatabase analysis of dosing patterns and infusion intervals for the first 12 infliximab infusions in patients with rheumatoid arthritis.
    Bolge SC; Carter CT; Mueller CS; Bailey RA; Ingham MP
    Clin Ther; 2012 Dec; 34(12):2286-92. PubMed ID: 23153660
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.